PRESENTIAL AND VIRTUAL
Mounting evidence implicates the microbiota of the digestive tract in the development and progression of diseases. Thus, there is a growing interest to modulate the microbiota to improve health state. It is recognized that the microbiota of each person is different. Part of theses differences are related to food intake.
Although the impact of each food component on microbiota is yet unclear, it opens new areas of research and potential treatment for diseases. It suggests that diseases may be modulated by nutrition and also paves the way for personalized medicine.
Recent studies suggest that the gut microbiota plays a key role in the appearance of metabolic syndrome and its associated features.
Many patients focus on nutrition with the aim to improve their gut microbiota dans ultimately their health.
A better understanding of the interactions between nutrition, pre- and probiotics and gut microbiota could open up new therapeutic options for chronic diseases.
Taking place in February 2022, our next symposium aims at summarizing the impact of oral intakes, whether nutrition, nutritional compounds or probiotics, in health and disease.
Microbiota refers to all microorganisms present in the human organism, whether bacteria, viruses, parasites or fungi.
It may be located in the digestive tract (oral, gut), but also on the skin and on any interface between the human body and the external world.
These micro-organisms likely interact with our immune and neurologic systems and appear to be linked with potential diseases.
Prof. Jacques Schrenzel (MD) is board-certified in internal medicine, in infectious diseases and in clinical microbiology. He is the co-founder of the Center of Excellence in Bacteriology at the University of Geneva (CEBUG). He is in charge of the bacteriological laboratory and the genomic research laboratory of Geneva University Hospitals (www.genomic.ch). He is recognized for his work on bioinformatics, metagenomics, microarrays and next-generation sequencing techniques, with the common objective to translate new techniques for patient care.
Prof. Laurence Genton (MD) is board-certified in internal medicine and working since over 20 years in clinical nutrition. She is president elect of the Swiss Society of Clinical Nutrition from 2014 until 2018 and member of the education committee of the European Society for Clinical Nutrition and Metabolism since 2017.
Her research work focuses on the link between nutrition state and energy expenditure and gut microbiota, and the impact of body composition on outcome.
Registration will allow you to have access to the presentations at the end of the symposium and to get the certificate of presence and the training credits including 3 FAMH formation credits. Click on the button !
Once again, microbiota specialists are participating at the high-quality Symposium nutrition and microbiota. Meet with them !
Prof. Jacques Schrenzel (MD) is board-certified in internal medicine, in ...
Physician in nutrition at the Geneva University Hospital, Switzerland. Specialist ...
We are grateful to the corporate and institutional sponsors that support the symposium. If you wish to participate to this growing journey, please contact us to discuss about the sponsorship opportunities.
This event is supported by the Swiss Society for Clinical Nutrition (SSNC/GESKES).
Post-gradual credits will be requested yearly for Internal medicine, general medicine, gastro-enterology, infectious diseases,
microbiology, endocrinology, diabetology, geriatrics, FPH, as well as the ASDD/SVDE.